Today's Top Performers In Health Services

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 78 points (0.5%) at 17,023 as of Friday, Sept. 26, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,765 issues advancing vs. 1,183 declining with 200 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is up 0.3%. A company within the industry that fell today was Agilent Technologies ( A), up 1.1%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. St Jude Medical ( STJ) is one of the companies pushing the Health Services industry higher today. As of noon trading, St Jude Medical is up $0.69 (1.1%) to $61.59 on light volume. Thus far, 446,705 shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $61.10-$61.72 after having opened the day at $61.26 as compared to the previous trading day's close of $60.90.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. St Jude Medical has a market cap of $17.7 billion and is part of the health care sector. Shares are down 1.3% year-to-date as of the close of trading on Thursday. Currently there are 15 analysts who rate St Jude Medical a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full St Jude Medical Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Baxter International ( BAX) is up $0.77 (1.1%) to $72.05 on average volume. Thus far, 1.6 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $71.57-$72.35 after having opened the day at $71.63 as compared to the previous trading day's close of $71.28.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $39.1 billion and is part of the health care sector. Shares are up 2.5% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Covidien ( COV) is up $1.60 (1.8%) to $90.01 on average volume. Thus far, 3.1 million shares of Covidien exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $88.46-$90.36 after having opened the day at $88.62 as compared to the previous trading day's close of $88.41.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $40.4 billion and is part of the health care sector. Shares are up 29.8% year-to-date as of the close of trading on Thursday. Currently there are 8 analysts who rate Covidien a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Covidien Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists